The handover of Gucci’s beauty license from Kering’s in-house operation to Coty, a process years in the making, has reached its final phase. Coty now controls the fragrance, cosmetics, and skincare businesses for one of the world’s most valuable luxury brands, a transfer that reshapes both companies’ beauty strategies and sets up a direct competitive dynamic with L’Oréal’s Luxe division and Estée Lauder Companies.
For the broader industry, the Gucci-Coty deal signals a cyclical return to the licensing model that dominated luxury beauty for decades, but with a crucial difference. Today’s beauty license requires the licensee to deliver not just distribution but innovation, with dedicated R&D, sustainability commitments, and digital-first marketing capabilities that the old model never demanded. The Gucci name will drive store traffic, but the quality of the juice and the consistency of the brand experience will determine whether this second marriage outlasts the first.
Coty’s acquisition of the Gucci license is the centerpiece of a broader luxury beauty strategy that has seen the company also acquire or renew licenses for Burberry Beauty and Chloe Fragrances. The group has invested in manufacturing capacity and fragrance creation capabilities, positioning itself as the premier alternative to L’Oréal Luxe for brands seeking a scale partner rather than a licensing competitor.
The handover includes Gucci’s entire beauty portfolio: the Makeup collection launched under Kering’s tenure, the Alchemist’s Garden fragrance line, the Flora and Bloom franchises, and a skincare pipeline that was in late-stage development. Coty is expected to streamline the product range, exit categories where Gucci has not achieved critical mass, and double down on the fragrance pillar that represents the majority of Gucci Beauty’s estimated $1.2 billion in annual retail sales.
